Edge Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Edge Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,000	Closed	-$73K	–	459
2020 Q4	$73K	Sell	1,000 -1,500	-60%	-$111K	0.02%	159
2020 Q3	$194K	Buy	+2,500	New	+$172K	0.04%	109
2020 Q2	–	Sell	-200	Closed	-$6K	–	728
2020 Q1	$6K	Buy	+200	New	+$6.77K	﹤0.01%	464
2017 Q2	–	Sell	-1,000	Closed	-$15K	–	579
2017 Q1	$15K	Sell	1,000 -9,000	-90%	-$146K	0.01%	312
2016 Q4	$162K	Buy	10,000 +9,000	+900%	+$163K	0.06%	125
2016 Q3	$18K	Buy	+1,000	New	+$19.5K	0.01%	282
2016 Q2	–	Sell	-800	Closed	-$13K	–	498
2016 Q1	$13K	Buy	+800	New	+$14K	0.01%	264

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Edge Wealth Management's HZNP Position: Q1 2021 in Review

Edge Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 1,000 shares — an estimated $73K sold.

Edge Wealth Management first reported a position in HZNP in Q1 2016 and held it in 7 quarters. The position peaked at $194K in Q3 2020. 517 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

Edge Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Edge Wealth Management sold 1,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $73K.
Edge Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016 and held it in 7 quarters.
Edge Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $194K in Q3 2020.
517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Edge Wealth Management's 13F filing for Q1 2021, filed 9 Apr 2021.